UBS AG - CYTORI THERAPEUTICS INC ownership

CYTORI THERAPEUTICS INC's ticker is CYTX and the CUSIP is 23283K105. A total of 74 filers reported holding CYTORI THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 1.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS AG ownership history of CYTORI THERAPEUTICS INC
ValueSharesWeighting
Q3 2014$5,000
-92.2%
7,100
-73.7%
0.00%
Q2 2014$64,000
-25.6%
26,955
-14.8%
0.00%
Q1 2014$86,000
-22.5%
31,620
-26.9%
0.00%
Q4 2013$111,000
+18.1%
43,270
+7.4%
0.00%
Q3 2013$94,000
-35.6%
40,300
-36.6%
0.00%
Q2 2013$146,00063,5150.00%
Other shareholders
CYTORI THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 599,295$293,0000.25%
MARATHON CAPITAL MANAGEMENT 349,000$171,0000.16%
GOLDMAN CAPITAL MANAGEMENT INC 415,000$204,0000.11%
PRINCETON CAPITAL MANAGEMENT INC 350,890$171,0000.10%
Redmond Asset Management, LLC 167,921$82,0000.04%
SABBY MANAGEMENT, LLC 2,096,392$1,025,0000.03%
Noven Financial Group, Inc. 52,555$26,0000.02%
Dominick & Dominick LLC 24,350$12,0000.01%
Spark Investment Management LLC 45,900$22,0000.00%
EXENCIAL WEALTH ADVISORS, LLC 10,000$5,0000.00%
View complete list of CYTORI THERAPEUTICS INC shareholders